The is a huge difference between marketing/promoting a drug, and letting the world know that you are having good results in clinical trials. It is ALREADY out in the world, to a small audience, that we have been doing well in clinical trials, and now we need our PR firm to step up and get coverage by meaningful news agencies. Again, many other companies are already getting such coverage and are nowhere near as far along as CYDY is with leronlimab.